Literature DB >> 16239184

Frontotemporal dementia.

David Neary1, Julie Snowden, David Mann.   

Abstract

Frontotemporal dementia (FTD) is a focal clinical syndrome characterised by profound changes in personality and social conduct and associated with circumscribed degeneration of the prefrontal and anterior temporal cortex. Onset is typically in the middle years of life and survival is about 8 years. The presence of microtubule-associated-protein-tau-based pathological features in some patients and the discovery, in some familial cases, of mutations in the tau gene links FTD to other forms of tauopathy, such as progressive supranuclear palsy and corticobasal degeneration. However, more than half of all patients with FTD, including some with a strong family history, show no apparent abnormality in the tau gene or protein, indicating pathological and aetiological heterogeneity. FTD provides a challenge both for clinical management and for theoretical understanding of its neurobiological substrate.

Entities:  

Mesh:

Year:  2005        PMID: 16239184     DOI: 10.1016/S1474-4422(05)70223-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  161 in total

1.  When laughing is no joking matter.

Authors:  Roy Yaari; Helle Brand; James D Seward; Anna D Burke; Adam S Fleisher; Jan Dougherty; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Frontotemporal dementia-a chameleon?

Authors:  Inyene E Umoren; Jean M Fils; Jonathan T Stewart
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia.

Authors:  Andrea Slachevsky; Carlos Muñoz-Neira; Javier Nuñez-Huasaf; Theodore A Stern; Carl R Blesius; Alireza Atri
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples.

Authors:  Virginia E Sturm; Megan E McCarthy; Ira Yun; Anita Madan; Joyce W Yuan; Sarah R Holley; Elizabeth A Ascher; Adam L Boxer; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-29       Impact factor: 3.436

5.  A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Michael Malek-Ahmadi; Sarah E Monsell; Walter A Kukull; Bryan K Woodruff; Eric M Reiman; Thomas G Beach; Jeffrey Wilson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

6.  Feasibility and acceptance of simultaneous amyloid PET/MRI.

Authors:  Lisa Schütz; Donald Lobsien; Dominik Fritzsch; Solveig Tiepolt; Peter Werner; Matthias L Schroeter; Jörg Berrouschot; Dorothee Saur; Swen Hesse; Thies Jochimsen; Michael Rullmann; Bernhard Sattler; Marianne Patt; Hermann-Josef Gertz; Arno Villringer; Joseph Claßen; Karl-Titus Hoffmann; Osama Sabri; Henryk Barthel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-19       Impact factor: 9.236

7.  Diminished disgust reactivity in behavioral variant frontotemporal dementia.

Authors:  Janet A Eckart; Virginia E Sturm; Bruce L Miller; Robert W Levenson
Journal:  Neuropsychologia       Date:  2012-01-20       Impact factor: 3.139

8.  Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy.

Authors:  Rosa Capozzo; Celeste Sassi; Monia B Hammer; Simona Arcuti; Chiara Zecca; Maria R Barulli; Rosanna Tortelli; J Raphael Gibbs; Cynthia Crews; Davide Seripa; Francesco Carnicella; Claudia Dell'Aquila; Marco Rossi; Filippo Tamma; Francesco Valluzzi; Bruno Brancasi; Francesco Panza; Andrew B Singleton; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2017-03-03       Impact factor: 21.566

Review 9.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 10.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.